152 related articles for article (PubMed ID: 25031781)
1. Analysis of male reproductive parameters in a murine model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Junior OA; D'Almeida V
Int J Clin Exp Pathol; 2014; 7(6):3488-97. PubMed ID: 25031781
[TBL] [Abstract][Full Text] [Related]
2. Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Aguiar O; Viana GM; D'Almeida V
Mol Biol Rep; 2021 Jan; 48(1):363-370. PubMed ID: 33319323
[TBL] [Abstract][Full Text] [Related]
3. Morphologic description of male reproductive accessory glands in a mouse model of mucopolysaccharidosis type I (MPS I).
do Nascimento CC; Junior OA; D'Almeida V
J Mol Histol; 2020 Apr; 51(2):137-145. PubMed ID: 32162173
[TBL] [Abstract][Full Text] [Related]
4. Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I).
Barbosa Mendes A; do Nascimento CC; D'Almeida V
PLoS One; 2019; 14(12):e0220429. PubMed ID: 31834922
[TBL] [Abstract][Full Text] [Related]
5. Evidence that glycosaminoglycan storage and collagen deposition in the cauda epididymidis does not impair sperm viability in the Mucopolysaccharidosis type I mouse model.
do Nascimento CC; Aguiar O; Viana GM; D Almeida V
Reprod Fertil Dev; 2020 Feb; 32(3):304-312. PubMed ID: 31679559
[TBL] [Abstract][Full Text] [Related]
6. Biomechanical and histological characterization of MPS I mice femurs.
Ferreira NY; do Nascimento CC; Pereira VG; de Oliveira F; Medalha CC; da Silva VC; D'Almeida V
Acta Histochem; 2021 Feb; 123(2):151678. PubMed ID: 33434858
[TBL] [Abstract][Full Text] [Related]
7. Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice.
Baldo G; Mayer FQ; Martinelli B; Dilda A; Meyer F; Ponder KP; Giugliani R; Matte U
Behav Brain Res; 2012 Jul; 233(1):169-75. PubMed ID: 22580166
[TBL] [Abstract][Full Text] [Related]
8. Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome.
Pan D; Sciascia A; Vorhees CV; Williams MT
Brain Res; 2008 Jan; 1188():241-53. PubMed ID: 18022143
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.
Wang D; Shukla C; Liu X; Schoeb TR; Clarke LA; Bedwell DM; Keeling KM
Mol Genet Metab; 2010 Jan; 99(1):62-71. PubMed ID: 19751987
[TBL] [Abstract][Full Text] [Related]
10. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene.
Hartung SD; Frandsen JL; Pan D; Koniar BL; Graupman P; Gunther R; Low WC; Whitley CB; McIvor RS
Mol Ther; 2004 Jun; 9(6):866-75. PubMed ID: 15194053
[TBL] [Abstract][Full Text] [Related]
11. An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life.
Kingma SD; Langereis EJ; de Klerk CM; Zoetekouw L; Wagemans T; IJlst L; Wanders RJ; Wijburg FA; van Vlies N
Orphanet J Rare Dis; 2013 Jul; 8():99. PubMed ID: 23837464
[TBL] [Abstract][Full Text] [Related]
12. The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse.
Wang D; Belakhov V; Kandasamy J; Baasov T; Li SC; Li YT; Bedwell DM; Keeling KM
Mol Genet Metab; 2012 Jan; 105(1):116-25. PubMed ID: 22056610
[TBL] [Abstract][Full Text] [Related]
13. Long-term nonsense suppression therapy moderates MPS I-H disease progression.
Gunn G; Dai Y; Du M; Belakhov V; Kandasamy J; Schoeb TR; Baasov T; Bedwell DM; Keeling KM
Mol Genet Metab; 2014 Mar; 111(3):374-381. PubMed ID: 24411223
[TBL] [Abstract][Full Text] [Related]
14. Decreased performance in IDUA knockout mouse mimic limitations of joint function and locomotion in patients with Hurler syndrome.
Kim C; Kwak MJ; Cho SY; Ko AR; Rheey J; Kwon JY; Chung Y; Jin DK
Orphanet J Rare Dis; 2015 Sep; 10():121. PubMed ID: 26407983
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatment.
Lizzi Lagranha V; Zambiasi Martinelli B; Baldo G; Ávila Testa G; Giacomet de Carvalho T; Giugliani R; Matte U
J Mater Sci Mater Med; 2017 Mar; 28(3):43. PubMed ID: 28150116
[TBL] [Abstract][Full Text] [Related]
16. In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system.
Schuh RS; Poletto É; Pasqualim G; Tavares AMV; Meyer FS; Gonzalez EA; Giugliani R; Matte U; Teixeira HF; Baldo G
J Control Release; 2018 Oct; 288():23-33. PubMed ID: 30170069
[TBL] [Abstract][Full Text] [Related]
17. Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficits.
Baldo G; Wozniak DF; Ohlemiller KK; Zhang Y; Giugliani R; Ponder KP
J Inherit Metab Dis; 2013 May; 36(3):499-512. PubMed ID: 22983812
[TBL] [Abstract][Full Text] [Related]
18. Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.
Kuehn SC; Koehne T; Cornils K; Markmann S; Riedel C; Pestka JM; Schweizer M; Baldauf C; Yorgan TA; Krause M; Keller J; Neven M; Breyer S; Stuecker R; Muschol N; Busse B; Braulke T; Fehse B; Amling M; Schinke T
Hum Mol Genet; 2015 Dec; 24(24):7075-86. PubMed ID: 26427607
[TBL] [Abstract][Full Text] [Related]
19. Alterations of membrane lipids and in gene expression of ganglioside metabolism in different brain structures in a mouse model of mucopolysaccharidosis type I (MPS I).
Kreutz F; dos Santos Petry F; Camassola M; Schein V; Guma FC; Nardi NB; Trindade VM
Gene; 2013 Sep; 527(1):109-14. PubMed ID: 23774686
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Endovascular and Intraventricular Gene Therapy With Adeno-Associated Virus-α-L-Iduronidase for Hurler Disease.
Janson CG; Romanova LG; Leone P; Nan Z; Belur L; McIvor RS; Low WC
Neurosurgery; 2014 Jan; 74(1):99-111. PubMed ID: 24077583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]